Towards a vaccine against Plasmodium vivax malaria.
Beeson
James G
JG
Infection and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria,Australia. beeson@wehi.edu.au
Crabb
Brendan S
BS
D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood / Q000276:immunology*; D000953:Antigens, Protozoan / Q000276:immunology* / Q000378:metabolism; D015195:Drug Design; D004375:Duffy Blood-Group System / Q000378:metabolism*; D004912:Erythrocytes / Q000276:immunology* / Q000378:metabolism / Q000469:parasitology; D006801:Humans; D017780:Malaria Vaccines / Q000276:immunology*; D016780:Malaria, Vivax / Q000276:immunology* / Q000378:metabolism; D010446:Peptide Fragments / Q000276:immunology; D010966:Plasmodium vivax / Q000276:immunology / Q000378:metabolism / Q000472:pathogenicity*; D015800:Protozoan Proteins / Q000276:immunology* / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000276:immunology* / Q000378:metabolism*; D011994:Recombinant Proteins / Q000276:immunology
C473745:ACKR1 protein, human; D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D004375:Duffy Blood-Group System; C066001:Duffy antigen binding protein, Plasmodium; D017780:Malaria Vaccines; D010446:Peptide Fragments; D015800:Protozoan Proteins; D011956:Receptors, Cell Surface; D011994:Recombinant Proteins